Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulf-Hakan Stenman

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Chemistry|November 25, 2003
Immunopeptidometric assay for enzymatically active prostate-specific antigenPing Wu, Lei Zhu, Ulf-Hakan Stenman, et al.
International Journal of Cancer|February 21, 2003
Expression of the free beta-subunit of human chorionic gonadotropin in renal cell carcinoma: prognostic study on tissue and serumKristina Hotakainen, Börge Ljungberg, Caj Haglund, et al.
Urology|August 11, 2007
Comparison of two different artificial neural networks for prostate biopsy indication in two different patient populationsCarsten Stephan, Chuanliang Xu, Patrik Finne, et al.
European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [Et Al] = Zeitschrift Fur Kinderchirurgie|September 6, 2017
No Tissue Expression of KRAS or BRAF Mutations in 61 Adult Patients Treated for Esophageal Atresia in Early ChildhoodKien Xuan Dang, Tho Ho, Saara Sistonen, et al.
Journal of Medical Screening|August 12, 2016
Design-corrected variation by centre in mortality reduction in the ERSPC randomised prostate cancer screening trialMatti Hakama, Sue M Moss, Ulf-Hakan Stenman, et al.
Reproductive Biomedicine Online|June 26, 2017
Optimizing bone morphogenic protein 4-mediated human embryonic stem cell differentiation into trophoblast-like cells using fibroblast growth factor 2 and transforming growth factor-β/activin/nodal signalling inhibitionMariann Koel, Urmo Võsa, Kaarel Krjutškov, et al.
Nucleic Acids Research|November 8, 2014
Extendable blocking probe in reverse transcription for analysis of RNA variants with superior selectivityTho H Ho, Kien X Dang, Susanna Lintula, et al.
Cancer Research|February 20, 2003
The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosisLiu-Ying Luo, Dionyssios Katsaros, Andreas Scorilas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinomaEleftherios P Diamandis, Andreas Scorilas, Stefano Fracchioli, et al.
World Journal of Urology|March 3, 2007
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 menCarsten Stephan, Chuanliang Xu, Henning Cammann, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Chemistry|November 25, 2003
Immunopeptidometric assay for enzymatically active prostate-specific antigenPing Wu, Lei Zhu, Ulf-Hakan Stenman, et al.
International Journal of Cancer|February 21, 2003
Expression of the free beta-subunit of human chorionic gonadotropin in renal cell carcinoma: prognostic study on tissue and serumKristina Hotakainen, Börge Ljungberg, Caj Haglund, et al.
Urology|August 11, 2007
Comparison of two different artificial neural networks for prostate biopsy indication in two different patient populationsCarsten Stephan, Chuanliang Xu, Patrik Finne, et al.
European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [Et Al] = Zeitschrift Fur Kinderchirurgie|September 6, 2017
No Tissue Expression of KRAS or BRAF Mutations in 61 Adult Patients Treated for Esophageal Atresia in Early ChildhoodKien Xuan Dang, Tho Ho, Saara Sistonen, et al.
Journal of Medical Screening|August 12, 2016
Design-corrected variation by centre in mortality reduction in the ERSPC randomised prostate cancer screening trialMatti Hakama, Sue M Moss, Ulf-Hakan Stenman, et al.
Reproductive Biomedicine Online|June 26, 2017
Optimizing bone morphogenic protein 4-mediated human embryonic stem cell differentiation into trophoblast-like cells using fibroblast growth factor 2 and transforming growth factor-β/activin/nodal signalling inhibitionMariann Koel, Urmo Võsa, Kaarel Krjutškov, et al.
Nucleic Acids Research|November 8, 2014
Extendable blocking probe in reverse transcription for analysis of RNA variants with superior selectivityTho H Ho, Kien X Dang, Susanna Lintula, et al.
Cancer Research|February 20, 2003
The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosisLiu-Ying Luo, Dionyssios Katsaros, Andreas Scorilas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinomaEleftherios P Diamandis, Andreas Scorilas, Stefano Fracchioli, et al.
World Journal of Urology|March 3, 2007
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 menCarsten Stephan, Chuanliang Xu, Henning Cammann, et al.
Pageof 2